NIH Launches COVID-19 Clinical Trial Network

The National Institutes of Health yesterday said it established a clinical trial network for large-scale clinical testing of COVID-19 investigational vaccines and monoclonal antibodies. The COVID-19 Prevention Trials Network will operate under the National Institute of Allergy and Infectious Diseases to enroll thousands of volunteers, according to NIH, as a functional unit of federal “Operation Warp Speed” initiative. The network will use a harmonized vaccine protocol developed by a public-private partnership to enable analyses of results across multiple clinical trials. Read more here.